News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
489,435 Results
Type
Article (29492)
Company Profile (75)
Press Release (459861)
Multimedia
Podcasts (60)
Webinars (12)
Section
Business (145597)
Career Advice (687)
Deals (21889)
Drug Delivery (95)
Drug Development (50813)
Employer Resources (63)
FDA (13656)
Job Trends (10515)
News (220121)
Policy (22162)
Tag
2025 Best Places to Work (9)
2026 Best Places to Work (15)
2027 BioCapital Standard (3)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Standard (5)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
40 Under 40 (2)
Academia (2039)
Accelerated approval (44)
ADA (34)
Adcomms (12)
Allergies (178)
Alliances (35066)
ALS (175)
Alzheimer's disease (1308)
Antibody-drug conjugate (ADC) (456)
Approvals (14492)
Artificial intelligence (740)
ASCO (216)
Autoimmune disease (317)
Automation (67)
Bankruptcy (187)
Belgium (35)
Best Places to Work (8666)
BIO (42)
Biologics (79)
Biomarkers (1)
BIOSECURE Act (6)
Biosimilars (172)
BioSpace Insights (103)
Biotechnology (47)
Bispecific (55)
Bladder cancer (201)
Brain cancer (67)
Breast cancer (656)
Cancer (5417)
Cardiovascular disease (432)
Career advice (635)
Career pathing (29)
CAR-T (224)
CDC (40)
CDMO (100)
Celiac Disease (8)
Cell-line development (1)
Cell therapy (664)
Cervical cancer (58)
Clinical research (47993)
Collaboration (1917)
Commercialization (63)
Company closure (2)
Compensation (476)
Complete response letters (42)
COVID-19 (1833)
CRISPR (92)
CRO (7)
C-suite (1127)
Cystic fibrosis (85)
Data (7976)
Decentralized trials (3)
Denatured (35)
Depression (148)
Dermatology (164)
Diabetes (573)
Diagnostics (5862)
Digital health (72)
Diversity (9)
Diversity, equity & inclusion (20)
Drug discovery (266)
Drug pricing (166)
Drug shortages (25)
Duchenne muscular dystrophy (190)
Earnings (49822)
Editorial (46)
Employer branding (6)
Employer resources (63)
ESMO (418)
Events (69039)
Executive appointments (967)
Eye disease (15)
FDA (17800)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (4)
Friedreich's ataxia (12)
Frontotemporal dementia (20)
Funding (1438)
Gene editing (160)
Generative AI (52)
Gene therapy (522)
GLP-1 (778)
Government (3600)
Grass and pollen (4)
Guidances (344)
Healthcare (14662)
Hematology (156)
HIV (97)
Huntington's disease (44)
Idiopathic pulmonary fibrosis (13)
IgA nephropathy (95)
Immunology and inflammation (123)
Immuno-oncology (90)
Indications (237)
Infectious disease (2104)
Inflammatory bowel disease (178)
Inflation Reduction Act (13)
Influenza (99)
Intellectual property (223)
Interviews (82)
IPO (9528)
IRA (41)
Job creations (2106)
Job search strategy (538)
JPM (23)
Kidney cancer (21)
Kidney disease (124)
Labor market (75)
Layoffs (260)
Leadership (23)
Legal (4375)
Licensing (78)
Liver cancer (84)
Longevity (31)
Lung cancer (829)
Lung diease (18)
Lymphoma (418)
Machine learning (51)
Management (26)
Manufacturing (973)
Marketing (29)
MASH (164)
Medical affairs (6)
Medical device (14442)
Medtech (14768)
Melanoma (94)
Mergers & acquisitions (13490)
Metabolic disorders (1293)
Middle East (2)
mRNA (149)
Multiple sclerosis (185)
Multispecific (2)
NASH (12)
Netherlands (30)
Neurodegenerative disease (340)
Neuropsychiatric disorders (73)
Neuroscience (2657)
Neurotech (1)
NextGen: Class of 2026 (4915)
Non-profit (3398)
Now hiring (57)
Obesity (523)
Opinion (172)
Ovarian cancer (222)
Pain (273)
Pancreatic cancer (299)
Parkinson's disease (290)
Partnered (35)
Patents (449)
Patient advocacy (8)
Patient recruitment (738)
Patient selection (83)
Peanut (57)
People (42840)
Peptides (31)
Pharmaceutical (17)
Pharmacy benefit managers (30)
Phase 1 (13731)
Phase 2 (20783)
Phase 3 (17118)
Pipeline (10499)
Policy (207)
Postmarket research (1760)
Preclinical (4443)
Press Release (31)
Prostate cancer (317)
Psychedelics (42)
Radioligand (2)
Radiopharmaceuticals (314)
Rare diseases (887)
Real estate (3795)
Recruiting (25)
Regenerative medicine (32)
Regulatory (19631)
Reports (39)
Research institute (2016)
Resumes & cover letters (90)
Rett syndrome (38)
RNA editing (15)
RSV (58)
Saudi Arabia (1)
Schizophrenia (172)
Series A (246)
Series B (155)
Series C (1)
Service/supplier (7)
Sickle cell disease (86)
Special edition (12)
Spinal muscular atrophy (120)
Sponsored (39)
Startups (2464)
State (1)
Stem cells (5)
Stomach cancer (12)
Substance use disorders (17)
Supply chain (110)
Switzerland (18)
Tariffs (47)
Tax incentives (2)
The Weekly (25)
Vaccines (762)
Venture capital (60)
Weight loss (337)
Wet AMD (4)
Women's health (149)
Worklife (9)
Date
Today (61)
Last 7 days (438)
Last 30 days (2418)
Last 365 days (20524)
2026 (18867)
2025 (20058)
2024 (23867)
2023 (27173)
2022 (36382)
2021 (39729)
2020 (39679)
2019 (35525)
2018 (26854)
2017 (22689)
2016 (21729)
2015 (25085)
2014 (18949)
2013 (15874)
2012 (17141)
2011 (17504)
2010 (15667)
Location
Africa (460)
Alabama (52)
Alaska (4)
Arizona (350)
Arkansas (13)
Asia (29970)
Australia (4645)
California (10327)
Canada (3198)
China (1537)
Colorado (573)
Connecticut (510)
Delaware (391)
Europe (64327)
Florida (1679)
Georgia (441)
Hawaii (4)
Idaho (53)
Illinois (1132)
India (105)
Indiana (700)
Iowa (28)
Japan (643)
Kansas (127)
Kentucky (49)
Louisiana (56)
Maine (48)
Maryland (1383)
Massachusetts (6717)
Michigan (344)
Minnesota (760)
Mississippi (8)
Missouri (171)
Montana (27)
Nebraska (26)
Nevada (131)
New Hampshire (87)
New Jersey (3418)
New Mexico (25)
New York (2786)
North Carolina (1432)
North Dakota (12)
Northern California (5134)
Ohio (421)
Oklahoma (19)
Oregon (37)
Pennsylvania (2236)
Puerto Rico (20)
Rhode Island (51)
South America (701)
South Carolina (96)
South Dakota (1)
Southern California (4264)
Tennessee (234)
Texas (1910)
United States (38858)
Utah (348)
Vermont (2)
Virginia (271)
Washington D.C. (60)
Washington State (750)
West Virginia (4)
Wisconsin (176)
Wyoming (3)
489,435 Results for "velocity medical solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Velocity Clinical Research appoints Justin Starzyk as Chief Executive Officer
September 18, 2026
·
4 min read
Press Releases
Valion Bio Receives Unsolicited Acquisition Interest in Velocity Bioworks; Weighs Strategic Options
October 26, 2026
·
6 min read
Press Releases
With Section 232 Tariffs Reshaping Biotech, Valion Bio’s Velocity Bioworks Capitalizes on Domestic CDMO Surge
October 14, 2026
·
6 min read
Press Releases
Velocity Clinical Research Appoints UK Medical Director
February 12, 2026
·
4 min read
IPO
Biotech IPOs approach ‘escape velocity’ barring yellow flags that could threaten rebound
Twenty-five biotechs have used the IPO route to go public this year—with five of those debuts occurring this month alone. It’s the most IPOs since 2021, when the industry recorded 78 during the height of the COVID-19 pandemic.
August 25, 2026
·
3 min read
·
Gabrielle Masson
Press Releases
NAMSA and Advanced Medical Solutions Announce Preferred Partnership
November 9, 2026
·
3 min read
Press Releases
Velocity Clinical Research Establishes a New Industry Benchmark, Entering 97% of Patient Data Within 24 Hours of Collection
August 27, 2026
·
3 min read
Press Releases
ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint
May 14, 2026
·
4 min read
Press Releases
Vapotherm® Announces FDA 510(k) Clearance for the All Patient Circuit™, Enabling High Velocity Therapy for Neonatal to Adult Patients
April 22, 2026
·
2 min read
Press Releases
Velocity Clinical Research Appoints Former Fortrea Executive, Andrew Reina, as Chief Revenue Officer
November 13, 2025
·
3 min read
1 of 48,944
Next